Molecular-genetic characterisation of gliomas that recur as same grade or higher grade tumours

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 5, 2004, Pages 723-726

  Hulsebos, T J M ^a   Troost, D ^a   Leenstra, S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 1942485897     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.025031     Document Type: Article

References (18)

1. Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000.
2. Ware ML, Berger MS, Binder DK. Molecular biology of glioma tumorigenesis. Histol Histopathol 2003;18:207-16.
3. Hulsebos TJM, Oskam NT, Troost D, et al. Dynamics of genetic alterations associated with glioma recurrence. Genes Chromosomes Cancer 1998;23:153-8.
4. Ino Y, Silver JS, Blazejewski L, et al. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. J Neuropathol Exp Neurol 1999;58:881-5.
5. Oskam NT, Bijleveld EH, Hulsebos TJM. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Inf J Cancer 2000;85:336-9.
6. Homelin R, Jego N, Laurent-Puig P, et al. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene 1993;8:2213-20.
7. Leenstra S, Oskam NT, Bijleveld EH, et al. Genetic sub-types of human malignant astrocytoma correlate with survival. Inf J Cancer 1998;79:159-65.
8. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-9.
9. Schmidt MC, Antweiler S, Urban N, et al. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 2002;61:321-8.
10. Von Deimling A, Fimmers R, Schmidt MC, et al. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000;59:544-58.
11. Nawell P. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
12. Dong ZQ, Pang JCS, Tong CY, et al. Clonality of oligoastrocytomas. Hum Pathol 2002;33:528-35.
13. Reifenberaer J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996;55:822-31.
14. Ishii N, Tada M, Hamou MF, et al. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene 1999;18:5870-8.
15. Jain AN, Chin K, Borresen-Dale AL, et al. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc Natl Acad Sci USA 2001;98:7952-7.
16. Schlegel J, Merdes A, Stumm G, et al. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Inf J Cancer 1994;56:72-7.
17. Von Deimling A, von Ammon K, Schoenfeld D, et al. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-25.
18. Kleihues P, Ohgaki H. Primary and secondary glioblastoma: from concept to clinical diagnosis. Neuro-oncol 1999;1:44-51.